Grigory M Dolganov

Title: Grigory M Dolganov: Innovator in Biotechnology

Introduction

Grigory M Dolganov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing human leukocyte interferon alpha-2. His work has led to the filing of multiple patents, showcasing his innovative approach to scientific challenges.

Latest Patents

Dolganov holds 2 patents, with his latest patent focusing on a recombinant plasmid DNA pVN 22 that codes for the biosynthesis of human leukocyte interferon alpha-2. This method involves submerged cultivation of a producer strain, specifically Pseudomonas species VG-84, which carries a plasmid pVG3 with an inserted gene for human leukocyte interferon alpha-2. The strain is cultivated in a nutrient medium containing carbon and nitrogen sources, mineral salts, and growth stimulants, under aeration and in the presence of antibiotics such as streptomycin or tetracycline. The process concludes with the isolation and purification of the end product.

Career Highlights

Throughout his career, Dolganov has worked with various research institutions, including the All-Union Research Institute of Genetics. His innovative methods have contributed to advancements in biotechnology and have had a lasting impact on the field.

Collaborations

Dolganov has collaborated with notable colleagues such as Viktor E Sterkin and Galina S Monastyrskaya. Their joint efforts have furthered research and development in the area of genetic engineering and biotechnology.

Conclusion

Grigory M Dolganov's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His innovative methods continue to pave the way for advancements in medical and genetic research.